Natco Pharma Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar ' 25	Mar ' 24	Mar ' 23	Mar ' 22	Mar ' 21

Sources of funds

Owner's fund

Equity share capital

35.80

35.80

36.50

36.50

36.50

Share application money

-

-

-

3.50

17.60

Preference share capital

-

-

-

-

-

Reserves & surplus

7,298.10

5,556.50

4,665.50

4,151.90

4,037.00

Loan funds

Secured loans

273.10

363.20

159.90

389.00

255.10

Unsecured loans

-

-

-

-

-

Total

7,607.00

5,955.50

4,861.90

4,580.90

4,346.20

Uses of funds

Fixed assets

Gross block

3,748.70

3,335.10

3,133.50

2,958.80

2,662.50

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

1,231.90

1,048.40

899.70

784.60

656.60

Net block

2,516.80

2,286.70

2,233.80

2,174.20

2,005.90

Capital work-in-progress

225.30

133.90

62.80

128.70

223.40

Investments

855.10

741.70

657.50

550.00

337.00

Net current assets

Current assets, loans & advances

4,672.70

3,391.70

2,433.80

2,125.10

2,186.20

Less : current liabilities & provisions

662.90

598.50

526.00

397.10

406.30

Total net current assets

4,009.80

2,793.20

1,907.80

1,728.00

1,779.90

Miscellaneous expenses not written

-

-

-

-

-

Total

7,607.00

5,955.50

4,861.90

4,580.90

4,346.20

Notes:

Book value of unquoted investments

173.50

143.00

126.60

84.10

68.00

Market value of quoted investments

191.20

109.40

98.90

121.10

119.80

Contingent liabilities

50.70

58.80

55.00

52.30

42.80

Number of equity sharesoutstanding (Lacs)

1791.10

1791.10

1825.20

1825.20

1823.38